BCR-ABL TYROSINE KINASE ACTIVITY MODULATES THE PHOSPHORYLATION AND THE LOCALIZATION OF INTERFERON REGULATORY FACTOR 5 (IRF-5) IN CHRONIC MYELOID LEUKEMIA CELLS

被引：0
|
作者：
Manzella, L. [1 ]
Massimino, M. [1 ]
Fallica, M. [1 ]
Consoli, M. L. [1 ]
Aloisi, A. [1 ]
Messina, A. [1 ]
Vigneri, P. [1 ]
机构：
[1] Univ Catania, Dept Biomed Sci, Sect Gen Pathol, Catania, Italy
来源：
HAEMATOLOGICA | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C052
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
  • [1] BCR-ABL Tyrosine Kinase Activity Modulates the Phosphorylation, Localization and Function of Interferon Regulatory Factor 5 (irf-5) in Chronic Myeloid Leukemia (CML) Cells
    Massimino, Michele
    Manzella, Livia
    Stagno, Fabio
    Consoli, Maria Letizia
    Fallica, Manuela
    Aloisi, Alessandra
    Di Raimondo, Francesco
    Messina, Angelo
    Vigneri, Paolo
    BLOOD, 2009, 114 (22) : 852 - 852
  • [2] BCR-ABL tyrosine kinase activity modulates the phosphorylation, localization and function of interferon regulatory factor 5 in chronic myeloid leukemia cells
    Manzella, L.
    Massimino, M.
    Consoli, M.
    Fidilio, A.
    Buffa, P.
    Fallica, M.
    Messina, A.
    Vigneri, P.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2010, 40 : 44 - 44
  • [3] Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
    Goldman, JM
    Melo, JV
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14): : 1084 - 1086
  • [4] Target spectrum of the BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia
    Hyewon Lee
    Igor Novitzky Basso
    Dennis Dong Hwan Kim
    International Journal of Hematology, 2021, 113 : 632 - 641
  • [5] Target spectrum of the BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia
    Lee, Hyewon
    Basso, Igor Novitzky
    Kim, Dennis Dong Hwan
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (05) : 632 - 641
  • [6] Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival
    Hamilton, Ashley
    Helgason, G. Vignir
    Schemionek, Mirle
    Zhang, Bin
    Myssina, Svetlana
    Allan, Elaine K.
    Nicolini, Franck E.
    Mueller-Tidow, Carsten
    Bhatia, Ravi
    Brunton, Valerie G.
    Koschmieder, Steffen
    Holyoake, Tessa L.
    BLOOD, 2012, 119 (06) : 1501 - 1510
  • [7] Bcr-Abl stabilizes β-catenin in chronic myeloid leukemia through its tyrosine phosphorylation
    Coluccia, Addolorata Maria Luce
    Vacca, Angelo
    Dunach, Mireia
    Mologni, Luca
    Redaelli, Sara
    Bustos, Victor H.
    Benati, Daniela
    Pinna, Lorenzo A.
    Gambacorti-Passerini, Carlo
    EMBO JOURNAL, 2007, 26 (05): : 1456 - 1466
  • [8] Heterocyclic Compounds as Bcr-Abl Tyrosine Kinase Inhibitors Against Chronic Myeloid Leukemia
    Gado, Sarah
    Hassan, Mohammed Al-Kassim
    Kisla, Mehmet Murat
    Ates-Alagoz, Zeynep
    MEDICINAL CHEMISTRY, 2024,
  • [9] BCR-ABL tyrosine kinase activity regulates the expression of multiple genes implicated in the pathogenesis of chronic myeloid leukemia
    Deininger, MWN
    Vieira, S
    Mendiola, R
    Schultheis, B
    Goldman, JM
    Melo, JV
    CANCER RESEARCH, 2000, 60 (07) : 2049 - 2055
  • [10] BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival
    Barbosa Pagnano, Katia Borgia
    Bendit, Israel
    Boquimpani, Carla
    De Souza, Carmino Antonio
    Miranda, Eliana C. M.
    Zalcberg, Ilana
    Larripa, Irene
    Nardinelli, Luciana
    Silveira, Rosana Antunes
    Fogliatto, Laura
    Spector, Nelson
    Funke, Vaneuza
    Pasquini, Ricardo
    Hungria, Vania
    Chiattone, Carlos Sergio
    Clementino, Nelma
    Conchon, Monika
    Beatriz Moiraghi, Elena
    Lopez, Jose Luis
    Pavlovsky, Carolina
    Pavlovsky, Miguel A.
    Cervera, Eduardo E.
    Antonio Meillon, Luis
    Simoes, Belinda
    Hamerschlak, Nelson
    Magarinos Bozzano, Alicia Helena
    Mayta, Ernesto
    Cortes, Jorge
    Bengio, Raquel M.
    CANCER INVESTIGATION, 2015, 33 (09) : 451 - 458
12345